Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Regular ✕HDFC Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseTataHDFC
NAV₹33.9323₹15.6450
NAV date20 Nov 202620 Nov 2026
History10.9 years4.0 years
Expense ratio2.4%2.1%
Stars★★★★★★★★★★
Growth Score65.7049.20

Returns

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
1 month+9.73%+7.59%
3 months+0.76%+1.66%
6 months+6.88%+11.28%
YTD+12.33%+6.77%
1 year+10.25%+4.91%
3 years (CAGR)+17.02%+10.77%
5 years (CAGR)+14.30%—
10 years (CAGR)+14.17%—
Since launch+11.82%+11.89%

Risk

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Volatility15.7%15.5%
Downside volatility10.1%10.5%
Sharpe0.670.28
Sortino1.040.41
Calmar1.000.56
Return / risk1.090.70
Deepest fall−21.94%−19.40%
Days to recover624234
Below its high−0.20%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Alpha−4.21%−0.70%
Beta1.000.92
R²90.2%90.6%
Up capture88.9%92.4%
Down capture105.4%94.3%
Tracking error4.9%4.9%
Information ratio−0.87−0.23
Treynor0.090.04

Consistency

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Best 1-year+73.72%+38.26%
Middle 1-year+7.27%+5.55%
Worst 1-year−18.70%−7.13%
1-year periods with a loss33.4%14.6%
Middle 3-year+19.29%+11.45%
Positive months61.1%61.1%
Best day+3.33%+4.11%
Worst day−3.10%−6.25%
Worst 5% day−1.35%−1.53%
Positive days54.9%54.3%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
5-year XIRR+16.33%—
5-year value₹9,09,680—
3-year XIRR+11.67%+7.42%
1-year XIRR+16.78%+13.95%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth